1
|
Collette C, Willhelm G, Del Bene VA, Aita SL, Marotta D, Myers T, Anderson J, Gammon M, Gerstenecker A, Nabors LB, Fiveash J, Triebel KL. Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls. Cancer Invest 2024; 42:671-681. [PMID: 39007916 PMCID: PMC11610445 DOI: 10.1080/07357907.2024.2371368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2022] [Revised: 03/30/2023] [Accepted: 06/19/2024] [Indexed: 07/16/2024]
Abstract
Limited research has compared cognition of people with non-central nervous system metastatic cancer (NCM) vs. metastatic brain cancer (BM). This prospective cross-sectional study was comprised 37 healthy controls (HC), 40 NCM, and 61 BM completing 10 neuropsychological tests. The NCM performed below HCs on processing speed and executive functioning tasks, while the BM group demonstrated lower performance across tests. Tasks of processing speed, verbal fluency, and verbal memory differentiated the clinical groups (BM < NCM). Nearly 20% of the NCM group was impaired on at least three neuropsychological tests whereas approximately 40% of the BM group demonstrated the same level of impairment.
Collapse
Affiliation(s)
- Christopher Collette
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Gabrielle Willhelm
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Victor A. Del Bene
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Stephen L. Aita
- Geisel School of Medicine at Dartmouth, Hanover, NH, 03755, United States of America
- Department of Mental Health, VA Maine Healthcare System, Augusta, ME, 04330, United States of America
| | - Dario Marotta
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Terina Myers
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Joseph Anderson
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Meredith Gammon
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - Adam Gerstenecker
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
| | - L. Burt Nabors
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
- Department of Radiation Oncology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
| | - John Fiveash
- Department of Radiation Oncology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
- O’Neal Comprehensive Cancer Center, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
| | - Kristen L. Triebel
- Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
- Department of Radiation Oncology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
| |
Collapse
|
2
|
Ahmed A, Smith M, Mandal S, Bushnik T. Who enrolls and why? Examining center-specific underlying patterns behind enrollment: a New York City-based traumatic brain injury model systems study. Brain Inj 2024; 38:19-25. [PMID: 38219046 DOI: 10.1080/02699052.2024.2304863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Accepted: 01/09/2024] [Indexed: 01/15/2024]
Abstract
BACKGROUND To elucidate the sociodemographic and study factors involved in enrollment in the Traumatic Brain Injury Model System (TBIMS) database, this study examined the effect of a variety of variables on enrollment at a local TBIMS center. METHODS A sample of 654 individuals from the local TBIMS center was studied examining enrollment by age, gender, race, ethnicity, homelessness status at date of injury, history of homelessness, health insurance status, presence of social support, primary language, consenting in hospital or after discharge, and the need for an interpreter. Binary logistic regression was conducted to identify variables that predict center-based enrollment into TBIMS. RESULTS Results demonstrated that older age was associated with decreasing enrollment (OR = 0.99, p = 0.01), needing an interpreter made enrollment less likely (OR = 0.33, p < 0.01), being primarily Spanish speaking predicted enrollment (OR = 3.20, p = 0.02), Hispanic ethnicity predicted enrollment (OR = 7.31, p = 0.03), and approaching individuals in the hospital predicted enrollment (OR = 6.94, p < 0.01). Here, OR denotes the odds ratio estimate from a logistic regression model and P denotes the corresponding p-value. CONCLUSIONS These results can be useful in driving enrollment strategies at this center for other similar TBI research, and to contribute a representative TBI sample to the national database.
Collapse
Affiliation(s)
- Asim Ahmed
- Rusk Rehabilitation at NYU Langone Health, Department of Rehabilitation, New York, NY, United States
- New York Medical College, School of Medicine, Valhalla, NY, United States
| | - Michelle Smith
- Rusk Rehabilitation at NYU Langone Health, Department of Rehabilitation, New York, NY, United States
| | - Soutrik Mandal
- NYU Grossman School of Medicine Department of Population Health, New York, NY, United States
| | - Tamara Bushnik
- Rusk Rehabilitation at NYU Langone Health, Department of Rehabilitation, New York, NY, United States
| |
Collapse
|
3
|
Gerstenecker A, Gammon M, Marotta D, Fiveash J, Nabors B, Mulhauser K, Triebel K. Clinical correlates of the ability to consent to research participation in brain metastasis. Psychooncology 2020; 29:1655-1661. [PMID: 33463869 DOI: 10.1002/pon.5487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Revised: 06/30/2020] [Accepted: 07/07/2020] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Impairment in the ability to provide informed consent is common in persons with brain metastasis. However, little is known about what factors contribute to this impairment in the patient group. Our objective is to determine if the associations between demographic, cognitive, and clinical variables correlate with the ability to provide informed consent in persons with brain metastasis. METHODS We administered a comprehensive neuropsychological battery to a group of 61 persons with brain metastasis. Demographic and clinical information was also collected. All diagnoses were made by board-certified oncologists and were verified histologically. Statistical analyses included Pearson's product-moment correlations, point biserial correlations, and linear regression. RESULTS Results indicated that combinations of education, verbal memory, executive function, whole brain radiation therapy, and chemotherapy affected various aspects of the ability to provide informed consent. Subsequent regression models demonstrated that these variables contributed a significant amount of shared variance to the ability to provide informed consent. CONCLUSION We found that the ability of persons with brain metastasis to provide informed consent is a cognitively complex ability that is also affected by education and treatment variables. This information can help clinical researchers in identifying persons with brain metastasis at risk of an impaired ability to provide informed consent and aid in the consenting process.
Collapse
Affiliation(s)
- Adam Gerstenecker
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA.,Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA.,Alzheimer's Disease Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Meredith Gammon
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA
| | - Dario Marotta
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA
| | - John Fiveash
- O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.,Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Burt Nabors
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA.,O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Kyler Mulhauser
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA
| | - Kristen Triebel
- Department of Neurology, Division of Neuropsychology, University of Alabama, Birmingham, Alabama, USA.,Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA.,O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|